The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 12, 2025

Filed:

Jul. 28, 2023
Applicant:

Illimis Therapeutics, Inc., Seoul, KR;

Inventors:

Chan Hyuk Kim, Daejeon, KR;

Won Suk Chung, Daejeon, KR;

Hyun Cheol Jung, Daejeon, KR;

Se Young Lee, Daejeon, KR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 19/00 (2006.01); A61P 25/28 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C07K 16/46 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/4703 (2013.01); A61P 25/28 (2018.01); C07K 16/18 (2013.01); A61K 38/00 (2013.01); C07K 2317/73 (2013.01); C07K 2319/74 (2013.01);
Abstract

A fusion molecule having phagocytosis-inducing activity is disclosed. The fusion molecule contains a first region capable of binding a TAM receptor and a second region capable of binding to a target substance of which aberrant accumulation is associated with or characteristic of diseases. The fusion molecule effectively clears and/or reduces and/or suppresses accumulated abnormal proteins, such as beta-amyloid, tau, alpha-synuclein, huntingtin, or prion, or the like. Uses of the fusion molecule are disclosed. The fusion molecule can be used for prevention or treatment of proteinosis caused by the abnormal accumulation of substances.


Find Patent Forward Citations

Loading…